NCT00001436View on ClinicalTrials.gov

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 31, 1995

Study Completion Date

September 30, 2000

Conditions

Neoplasm MetastasisOsteosarcoma

Interventions

DRUG

OncoLAR® (Registered Trademark)

DRUG

tamoxifen

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH